Guidance
Appendix C. Guidance on the use of fludarabine as second line therapy for B-cell chronic lymphocytic leukaemia
Appendix C. Guidance on the use of fludarabine as second line therapy for B-cell chronic lymphocytic leukaemia
'Understanding NICE Guidance', a summary of this guidance for patients and carers can be found on our website.